Biosimilar Litigation: Celltrion, Pfizer Claim Victory On Janssen’s Remaining Infringement Claim
Ensnarement defense bars Remicade maker from prevailing on claim that Inflectra partners infringed cell culture media patent, US federal judge rules.
Ensnarement defense bars Remicade maker from prevailing on claim that Inflectra partners infringed cell culture media patent, US federal judge rules.